Supply Chain Intelligence

Integra LifeSciences Holdings Corporation Supply Chain

IART supply chain intelligence for Integra LifeSciences Holdings Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

IART ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
15Customers
2Debt Items
20Related Chains

Integra LifeSciences Holdings Corporation Suppliers

TickerNameConfidenceEvidence
MDXG MiMedx Group, Inc. 72% Reciprocal relationship from MDXG graph: ls increase their purchases of our products during the fourth quarter to coincide with the end of their budget cycles in the United States. Satisfaction of pa…
MDXG MiMedx Group, Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitiv…
SMTI Sanara MedTech Inc. 72% Reciprocal relationship from SMTI graph: Reciprocal relationship from IART graph: Reciprocal relationship from SMTI graph: Reciprocal relationship from IART graph: Reciprocal relationship from SMTI g…
SNNUF Smith & Nephew plc 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
SNNUF Smith & Nephew plc 72% Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competiti…
STE STERIS plc 72% Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: usiness, including the U.S. These ini…
STE STERIS plc 72% usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical devices and therapies. Government programs, including Medicare and Medicaid, privat…

Integra LifeSciences Holdings Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-DEFENSE USGOV-DEPARTMENT-OF-DEFENSE 95% USAspending awards from Department of Defense: $85,694 across 2 awards. N0018924FZ272 IP2P BRAIN PROBE KITS; N0018925FZ586 IP2P BRAIN PROBE KITS | Qwen corrected direction: Explicit government contra…
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $88,210 across 1 awards. 75N90025P00591 25-007631 INTEGRA LIFESCIENCES CORPORATION CORDLESS HEADLIGHT SYSTEM AND BATTERIES | Qwen corr…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $651,740 across 7 awards. 36C24625P1066 INTEGRA ULTRASONIC SURGICAL ASPIRATOR SYSTEM; 36C26325P0886 ENT SURGICAL SHAVER; 36C25023P0645 HIGHLY S…
MDXG MiMedx Group, Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
MDXG MiMedx Group, Inc. 72% Reciprocal relationship from MDXG graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitiv…
ORGO Organogenesis Holdings Inc. 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
ORGO Organogenesis Holdings Inc. 72% Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: Reciprocal relationship from ORGO g…
SMTI Sanara MedTech Inc. 72% Reciprocal relationship from SMTI graph: ting room etiquette and credentialing requirements. After completing their internal training, new hire field sales representatives participate in field traini…
SNNUF Smith & Nephew plc 72% Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: Reciprocal relationship from SNNUF graph: Reciprocal relationship from IART graph: Reciprocal relationship from SNNU…
SNNUF Smith & Nephew plc 72% rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT include Smith & Nephew plc, Organogenesis Holdi…
STE STERIS plc 72% usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical devices and therapies. Government programs, including Medicare and Medicaid, privat…
STE STERIS plc 72% Reciprocal relationship from STE graph: Reciprocal relationship from IART graph: usiness, including the U.S. These initiatives put increased emphasis on the delivery of more cost-effective medical de…
GENTELL-LLC GENTELL-LLC 62% Acquisition On December 6, 2022, the Company completed its acquisition of Surgical Innovation Associates, Inc. (“SIA”) for an acquisition purchase price of $ 51.5 million (the “SIA Acquisition”) plus…
SURGICAL-INNOVATION-ASSOCIATES-INC SURGICAL-INNOVATION-ASSOCIATES-INC 62% easures. Governmental health systems have revised and continue to consider revisions of healthcare budgets, which could result in stricter standards for implementing certain medical procedures, incre…
TISSUE-TECHNOLOGIES TISSUE-TECHNOLOGIES 62% al (“CSS”) and Tissue Technologies (“TT”). The CSS segment, which represents approximately two-thirds of our total revenue, consists of market-leading technologies and instrumentation used for a wide…

Integra LifeSciences Holdings Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
IART-DEBT Debt stack $2.0B 90% Market cache reports total debt of $2.0B.
IART-DEBT-10158 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

Integra LifeSciences Holdings Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation Ownership

HolderNameConfidenceEvidence
IART-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 204 tracked holders.

Integra LifeSciences Holdings Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JNJ Johnson & Johnson 100.00 2
TELA TELA Bio, Inc. 100.00 2
SMTI Sanara MedTech Inc. 100.00 1 ['customer', 'supplier']
NDRA ENDRA Life Sciences Inc. 100.00 2
NPCE NeuroPace, Inc. 100.00 2
PLSE Pulse Biosciences, Inc. 100.00 2
MDXG MiMedx Group, Inc. 100.00 1 ['customer', 'supplier']
ORGO Organogenesis Holdings Inc. 100.00 1 ['customer', 'supplier']
AURX Nuo Therapeutics, Inc. 100.00 2
PYPD PolyPid Ltd. 100.00 2
CUPR Cuprina Holdings (Cayman) Limited 100.00 2
IHG InterContinental Hotels Group PLC 100.00 2
EW Edwards Lifesciences Corporation 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
DEO Diageo plc 100.00 2
MDWD MediWound Ltd. 100.00 2
GWW W.W. Grainger, Inc. 100.00 2
SSII SS Innovations International, Inc. 100.00 2
ISRG Intuitive Surgical, Inc. 100.00 2
XTNT Xtant Medical Holdings, Inc. 100.00 2
View IART supply chain intel →

Explore the full interactive supply chain map for Integra LifeSciences Holdings Corporation.

Open IART supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map